|
1
|
Alghamdi IG, Hussain II, Alghamdi MS and
El-Sheemy MA: The incidence rate of female breast cancer in Saudi
Arabia: An observational descriptive epidemiological analysis of
data from Saudi cancer registry 2001–2008. Breast Cancer (Dove Med
Press). 5:103–109. 2013.PubMed/NCBI
|
|
2
|
Ministri of Health (Saudi Arabia), .
Breast Cancer. Ministri of Healt; Riyadh: 2022, https://www.moh.gov.sa/en/HealthAwareness/EducationalContent/wh/Breast-Cancer/Pages/default.aspxMay
18–2022
|
|
3
|
Saudi Health Council, . Cancer Incidence
Report in Kingdom of Saudi Arabia 2018. Saudi Health Council;
Riyadh: 2018, https://shc.gov.sa/Arabic/NCC/Activities/AnnualReports/2018.pdf
|
|
4
|
National Cancer Institute (NIH), . SEER
Explorer: Rate of New Cases Death Rate [Internet]. NIH; Bethesda,
MD: 2018, https://seer.cancer.gov/statfacts/html/breast.html
|
|
5
|
Li J, Wang H, Geng C, Liu Z, Lin Y, Nie J,
Sun G, Ouyang Q, Wang X, Li X, et al: Suboptimal declines and
delays in early breast cancer treatment after COVID-19 quarantine
restrictions in China: A national survey of 8397 patients in the
first quarter of 2020. EClinicalMedicine. 26:1005032020. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ueda M, Martins R, Hendrie PC, McDonnell
T, Crews JR, Wong TL, McCreery B, Jagels B, Crane A, Byrd DR, et
al: Managing cancer care during the COVID-19 Pandemic: Agility and
collaboration toward a common goal. J Natl Compr Canc Netw. Mar
20–2020.(Epub ahead of print). View Article : Google Scholar
|
|
7
|
Rocco N, Montagna G, Di Micco R, Benson J,
Criscitiello C, Chen L, Di Pace B, Esgueva Colmenarejo AJ, Harder
Y, Karakatsanis A, et al: The Impact of the COVID-19 pandemic on
surgical management of breast cancer: Global trends and future
perspectives. Oncologist. 26:e66–e77. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Untch M, Konecny GE, Paepke S and von
Minckwitz G: Current and future role of neoadjuvant therapy for
breast cancer. Breast. 23:526–537. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang Q, Berger NA and Xu R: Analyses of
risk, racial disparity, and outcomes among US patients with cancer
and COVID-19 infection. JAMA Oncol. 7:220–227. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Schreiber RD, Old LJ and Smyth MJ: Cancer
immunoediting: Integrating immunity's roles in cancer suppression
and promotion. Science. 331:1565–1570. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ogle KS, Swanson GM, Woods N and Azzouz F:
Cancer and comorbidity: Redefining chronic diseases. Cancer.
88:653–663. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
The American Cancer Society, . Fever.
Cancer.org. 1.800.227.2345. American Cancer Society; Atlanta, GA:
2020
|
|
13
|
Oken MM, Creech RH, Tormey DC, Horton J,
Davis TE, McFadden ET and Carbone PP: Toxicity and response
criteria of the Eastern Cooperative Oncology Group. Am J Clin
Oncol. 5:649–655. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Giuliano AE, Connolly JL, Edge SB,
Mittendorf EA, Rugo HS, Solin LJ, Weaver DL, Winchester DJ and
Hortobagyi GN: Breast cancer-major changes in the American joint
committee on cancer eighth edition cancer staging manual. CA Cancer
J Clin. 67:290–303. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kutikov A, Weinberg DS, Edelman MJ,
Horwitz EM, Uzzo RG and Fisher RI: A war on two fronts: Cancer care
in the time of COVID-19. Ann Intern Med. 172:756–758. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Alsaleh K: Effect of COVID-19 pandemic on
oncology services and the impact of specific measures in reducing
the delays. J Appl Hematol. 12:74–78. 2021. View Article : Google Scholar
|
|
17
|
Docherty AB, Harrison EM, Green CA,
Hardwick HE, Pius R, Norman L, Holden KA, Read JM, Dondelinger F,
Carson G, et al: Features of 20 133 UK patients in hospital with
covid-19 using the ISARIC WHO clinical characterisation protocol:
Prospective observational cohort study. BMJ. 369:m19852020.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang L, Zhu F, Xie L, Wang C, Wang J,
Chen R, Jia P, Guan HQ, Peng L, Chen Y, et al: Clinical
characteristics of COVID-19-infected cancer patients: A
retrospective case study in three hospitals within Wuhan, China.
Ann Oncol. 31:894–901. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tashkandi E, Al-Abdulwahab A, Basulaiman
B, Alsharm A, Al-Hajeili M, Alshadadi F, Halawani L, Al-Mansour M,
Alquzi B, Barnawi S, et al: Mortality and morbidity of curative and
palliative anticancer treatments during the covid-19 pandemic: A
multicenter population-based retrospective study. Mol Clin Oncol.
14:822021. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Dave RV, Kim B, Courtney A, O'Connell R,
Rattay T, Taxiarchi VP, Kirkham JJ, Camacho EM, Fairbrother P,
Sharma N, et al: Breast cancer management pathways during the
COVID-19 pandemic: Outcomes from the UK ‘Alert Level 4’ phase of
the B-MaP-C study. Br J Cancer. 124:1785–1794. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Vuagnat P, Frelaut M, Ramtohul T, Basse C,
Diakite S, Noret A, Bellesoeur A, Servois V, Hequet D, Laas E, et
al: COVID-19 in breast cancer patients: A cohort at the Institut
Curie hospitals in the Paris area. Breast Cancer Res. 22:552020.
View Article : Google Scholar : PubMed/NCBI
|
